VANCOUVER, BC, Sept. 28, 2021 /CNW/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research in psychedelics, today announced that Kelsey Ramsden, President & CEO of MINDCURE, will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually on September 29-30, 2021. Investors can register for the conference here.
In addition, Ms. Ramsden will participate in one-on-one investor meetings during the conference. To schedule a one-on-one meeting, please contact KCSA Strategic Communications at MindCure@kcsa.com.